Nastri, Horacio G.,Iffland, Christel,Leger, Olivier,An, Qi,Cartwright, Mark,McKenna, Sean D.,Sood, Vanita D.,Hao, Gang
申请号：
AU2012344260
公开号：
AU2012344260A1
申请日:
2012.11.21
申请国别(地区):
AU
年份:
2014
代理人:
摘要：
The present application relates to anti-PD-L1 antibodies or antigen binding fragments thereof, nucleic acid encoding the same, therapeutic compositions thereof, and their use to enhance T-cell function to upregulate cell-mediated immune responses and for the treatment of T cell dysfunctional disorders, such as tumor immunity, for the treatment of and cancer.
